Figure 1. Expression of miR-500a was increased in serum and tissues of patients with hepatocarcinoma.

(A) Serum miR-500a expression was significantly increased in hepatocarcinoma patients compared with the normal people. (B) Serum miR-500a expression was significantly increased in metastatic hepatocarcinoma patients than non-metastatic ones. (C) Expression of miR-500a was significantly increased in tumor tissues compared with the adjacent tissue in metastatic and non-metastatic hepatocarcinoma patients. **P<0.01, compared with the non-metastatic group, the relative miR-500a expression in metastatic group had a significant difference.